Research Progress of the Treatment of PD-1 Immune CheckpointInhibitors in Oral Squamous Cell Carcinoma | Zendy

Ye-Tao Wang | Zendy; S. B. Qian | Zendy; Kesang Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Research Progress of the Treatment of PD-1 Immune CheckpointInhibitors in Oral Squamous Cell Carcinoma

Author(s) -

Ye-Tao Wang,

S. B. Qian,

Kesang Li

Publication year - 2020

Publication title -

journal of oncology research

Language(s) - English

Resource type - Journals

ISSN - 2630-5267

DOI - 10.30564/jor.v2i2.2429

Subject(s) - immunotherapy , medicine , refractory (planetary science) , immune checkpoint , basal cell , oncology , immune system , adverse effect , pd l1 , pembrolizumab , incidence (geometry) , cancer research , immunology , biology , physics , astrobiology , optics

1. Department of Hematology and Oncology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315000, China 2. Department of stomatology, Longsai Hospital, Ningbo, Zhejiang, 315200, China 3. Ningbo Institute of life and Health industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315200, China 4. Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang, 315200, China

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research